Christopher Leamon, VP of Research at Endocyte, holds 0.00 shares in Fusion Pharmaceuticals (Ticker: FUSN), holds 0.00 shares in Endocyte (Ticker: ECYT).
What is the percentage of profitable transactions made by Christopher Leamon?
The percentage of profitable transactions made by Christopher Leamon is ―.
What is the average return per transaction made by Christopher Leamon?
The average return per transaction made by Christopher Leamon is ―.
What stocks does Christopher Leamon hold?
Christopher Leamon holds: ECYT, FUSN stocks.
What was Christopher Leamon’s latest transaction?
Christopher Leamon latest transaction was an Uninformative Sell of ―.
What was Christopher Leamon's most profitable transaction?
Christopher Leamon’s most profitable transaction was an Informative Buy of ECYT stock on February 26, 2015. The return on the trade was -48.30%.
What is Christopher Leamon's role in Endocyte?
Christopher Leamon's role in Endocyte is VP of Research.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.